Measles vaccine efficacy is higher at 12 months than 9 months because of maternal immunity, but delaying vaccination exposes the children most vulnerable to measles mortality to infection. We explored how this trade-off changes as a function of regionally varying epidemiological drivers, e.g. demography, transmission seasonality, and vaccination coverage. High birth rates and low coverage both favour early vaccination, and initiating vaccination at 9-11 months, then switching to 12-14 months ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems.
If you are the owner of this record, you can report an update to it here: Report update to this record